Cyclical Cushing’s disease and its successful control under sodium valproate
Tóm tắt
Từ khóa
Tài liệu tham khảo
Lamberts S.W.J., De Lange S.A., Stefanko S.Z. Adenocorticotropin-secreting pituitary adenomas originate from the anterior or the intermediate lobe in Cushing’s disease: differences in the regulation of hormone secretion. J. Clin. Endocrinol. Metab. 54: 286, 1982.
Van Cauter E., Refetoff S. Evidence for two subtypes of Cushing’s disease on the analysis of episodic Cortisol secretion. N. Engl. J. Med. 312: 1343, 1985.
Brown R.D., Van Loon G.R., Orth D.N., Liddle G.W. Cushing’s disease with periodic hormonogenesis: one explanation for paradoxical response to dexa-methasone. J. Clin. Endocrinol. Metab. 36: 445, 1973.
Atkinson A.B., Chestnutt A., Crothers E., Woods R. Weaver J.A., Kennedy L., Sheridan B. Cyclical Cushing’s disease: two distinct rhythms in a patient with a basophil adenoma. J. Clin. Endocrinol. Metab. 60: 328, 1985.
Atkinson A.B., Kennedy A.L., Carson D.J, Hadden D.R., Weaver J.A., Sheridan B. Five cases of cyclical Cushing’s syndrome. Br. Med. J. 291: 1453, 1985.
Muller O.A., Stalla G.K., Hartwimmer J., Schopohl J., Von Werder K. Corticotropin releasing factor (CRF): diagnostic implications. Acta Neurochir. (Wien) 19C., 75(1-4), 49–59, 1985.
Merriam G, Wachter K. Algorythms for the study of episodic hormone secretion. Am. J. Physiol. 43: E310, 1982.
Knott G., Reece D. MLAB: A civilized curve fitting system. In: Proceedings of the online 72 International Conference, Vol. 1. Brunei University, London 1972, p. 497.
Stevenaert A, Beckers A., Vandalem J.L, Hennen G. Early normalization of luteinizing hormone pulsatility after successful transsphenoidal surgery in women with microprolactinomas. J. Clin. Endocrinol. Metab. 62: 1044, 1986.
Sternberger L.A., Hardy P.H., Cuculis J, Meyer H.G. The unlabeled antibody enzyme method of immuno-chemistry. Preparation and properties of soluble antigen-antibody complex (Horseradish peroxidase) and its use in the identification of spirochetes. J. Histochem. Cytochem. 18: 315, 1970.
Pieters G.F.F.M., Smals A.G.H., Goverde H.J.M., Pesman G.J., Meyer E, Kloppenborg P.W.C. Adrenocorticotropin and Cortisol responsiveness to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone discloses two subsets of patients with Cushing’s disease. J. Clin. Endocrinol. Metab. 55: 1188, 1982.
Bailey R.E. Periodic hormonogenesis: a new phenomenon. Periodicity in function of a hormone-producing tumor in man. J. Clin. Endocrinol. Metab. 32: 317, 1971.
Liberman B., Wajchenberg B., Tambascia MA, Mesquita C.H. Periodic remission in Cushing’s disease with paradoxical dexamethasone response: an expression of periodic hormono-genesis. J. Clin. Endocrinol. Metab. 43: 913, 1976.
Jordan R.M., Ramos-Gabatin A., Kendall J.W., Gaudette D., Walls R.C. Dynamics of adrenocorticotropin (ACTH) secretion in cyclic Cushing’s syndrome: evidence for more than one abnormal ACTH biorhythm. J. Clin. Endocrinol. Metab. 55: 531, 1982.
Birke G., Diczfalusy E., Plantin L. Fluctuations in the excretion of adrenocortical steroids in a case of Cushing’s syndrome. J. Clin. Endocrinol. Metab. 16: 286, 1956.
Chajek T., Romanoff H. Cushing’s syndrome with cyclical edema and periodic secretion of corticosteroids. Arch. Intern. Med. 136: 441, 1976.
Oates T.W., Mc Court J.P., Friedman W.A., Agee CF., Rhoton A.L, Thomas W.C. Cushing’s disease with cyclical hormonogenesis and diabeted insipidus. Neurosurgery 5: 598, 1979.
Halberg F. Chronobiology. In: Hall V.E., Giese A.C., Sonnenschein R.R. (Eds.), Annual Review of Physiology. Vol. 31, 1969, p. 675.
Dornhorst A., Jenkins J.S., Lamberts S.W.J., Abraham R.R., Wynn V., Beckford U., Gillham B., Jones M.T. The evaluation of sodium valproate in the treatment of Nelson’s syndrome. J. Clin. Endocrinol. Metab. 56: 985, 1983.
Loli P., Berselli M.E., Vignati F., De Grandi C., Tagliaferri M. Size reduction of an ACTH-secreting pituitary macroadenoma in Nelson’s syndrome by sodium valproate: effect withdrawal and reinstitution of treatment. Acta Endocrinol. (Copenh.) 119: 435, 1988.
Koppeschaar H.P.F., Croughs R.J.M, Thijssen J.H.H., Schwarz F. Sodium valproate and cyproheptadine may independently induce a remission in the same patient with Cushing’s disease. Acta Endocrinol. (Copenh.) 104: 160, 1983.
Koppeschaar H.P.F., Croughs R.J.M., Van’t Verlaat J.W., Hendriks M.J., Arts C.J.M., Thijssen J.H.H., Schwarz F. Successful treatment with sodium valproate of a patient with Cushing’s disease and gross enlargement of pituitary. Acta Endocrinol. (Copenh.) 107: 471, 1984.
Koppeschaar H.P.F., Croughs R.J.M., Thijssen J.H.H., Schwarz F. Response to neurotransmitter modulating drugs in patients with Cushing’s disease. Clin. Endocrinol. (Oxf.) 25: 661, 1986.
Jones M.T., Gillham B., Altaher A.R.H., Nicholson S.A., Campbell E.A., Watts S.M., Thody A. Clinical and experimental studies on the role of gaba in the regulation of ACTH secretion: a review. Psychoneuroendocrinology 9: 107, 1984.
Lamberts S.W.J., Verleu T., Bons E.G., Uitterlinden P., Oosterom R. Effect of cyproheptadine, desmethylcyproheptadine, gamma-aminobutyric acid and sodium valproate on adrenocorticotrophin secretion by cultured pituitary tumors cells from three patients with Nelson’s syndrome. J. Endocrinol. 96: 401, 1983.
Regan C.M. Therapeutic levels of sodium valproate inhibit mitotic indices in cells of neural origin. Brain Res. 347: 394, 1985.